tirzepatide natural source on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Experience the Power of Tirzepatide:

Increased Risk of Discontinuation: Unmanageable side effects are a primary reason people stop treatment

As a neuronal GLP-1R agonist, ROSE-010 increases smooth muscle motility in the gastrointestinal tract

Last Updated June 2026 Tirzepatide has moved from diabetes treatment to one of the most clinically supported weight loss medications available

Since you can administer it yourself, fewer clinic visits are a feature

The vial provides 4 doses (10 mg total / 2.5 mg per dose)

The drug is developed by CSPC Pharmaceutical Group and is one of a number of Chinese firm, who are looking to be a part of the lucrative field of slimming drugs